Hydrophobins as surface active proteins as excipients in solid pharmaceutical formulations

Details for Australian Patent Application No. 2009319183 (hide)

Owner BASF SE

Inventors Buthe, Andreas; Hafner, Andreas; Kaufmann, Franz; Gabor, Esther; Meurer, Guido; Eck, Jurgen; Bradley, Gordon

Agent Shelston IP

Pub. Number AU-A-2009319183

PCT Pub. Number WO2010/060811

Priority 08170101.3 27.11.08 EP

Filing date 13 November 2009

Wipo publication date 3 June 2010

International Classifications

C07K 14/37 (2006.01) Peptides having more than 20 amino acids - from fungi

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/28 (2006.01) Medicinal preparations characterised by special physical form - Dragees

Event Publications

21 July 2011 PCT application entered the National Phase

  PCT publication WO2010/060811 Priority application(s): WO2010/060811

15 September 2011 Assignment before Grant

  BASF SE The application has been assigned to B.R.A.I.N. Biotechnology Research and Information Network AG

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009319185-Therapeutic, dietary, or cosmetic use of compounds with specific anti-apoptotic activity toward caspase-3, and compositions containing these compounds

2009319175-Polypeptides, antibody variable domains & antagonists